CONTACT
+91 80 2808 2808
info@biocon.com
Biocon  /  Businesses  /  Biosimilars  /  Mandar S Ghatnekar

Mandar S Ghatnekar

Global Head of IT & Digital Transformation

Mandar S Ghatnekar

Global Head of IT & Digital Transformation

Dr Mandar S Ghatnekar is the Global Head of IT & Digital Transformation at Biocon Biologics and will be leading all IT & Digital Solutions initiatives.

Mandar has over two decades of IT advisory and consulting experience across the life sciences industry. He has led several enterprise transformation programs, driving innovative use of digital and automation technologies in R&D, manufacturing, supply chain, and commercial operations at global bio/pharma companies, CROs, and regulatory agencies.

Prior to joining Biocon Biologics, Mandar was Managing Director at Accenture’s Advanced Technology Center in India and before that, he worked at Johnson & Johnson, Infosys Technologies, Mascon Global and Biotechnology Resource Centre.

Mandar holds a Ph.D. and Masters from the Institute of Chemical Technology, Mumbai (formerly UDCT), and a Bachelors in Pharmaceutical Sciences from the University of Pune. He has over 20 publications in national and international peer-reviewed journals and he has presented at international conferences like the Bio-IT World Conference and DIA.

Share
Leaving the Biocon site!

You are now leaving the Biocon website for a Biocon affiliate site or third party site that is solely responsible for its content, including its compliance with guidelines applicable in certain geographies. Links to Biocon affiliate sites and third party sites are provided as a resource to our visitors and may not be governed by the same regulatory requirements applicable to this site and unaffiliated third party sites are subject to their own terms and data protection notices and practices. Moreover, if their third party site is subject to other country laws, regulatory requirements, data protection requirements or medical practices may differ between countries and the information provided therein may not be suitable for use in your country.

Agree >>